CME

CME Group
D

CME

Arincen73/100B

CME Group P/E ratio

CME Group's P/E ratio is 26.04: its share price of 319.28 over its earnings per share of 12.26 over the last twelve months.

Today
26.04
Forward P/E, next 12 months
24.30
PEG ratio
3.05
Median, 5 years
25.02
Low, 5 years
18.52
High, 5 years
36.73

P/E ratio = price ÷ EPS (last 12 months) = 319.28 ÷ 12.26 = 26.04

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is CME Group's P/E high compared with its own history?

CME Group's P/E of 26.0 is above the middle of its 5-year range (18.5 to 36.7, median 25.0). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 202724.10———
FY2026 · Estimate31 Dec 202625.75———
Today26.0424.30114.28B4.42B
FY202531 Dec 202524.1222.0398.21B4.07B
FY202431 Dec 202423.6720.7983.46B3.53B
FY202331 Dec 202323.4420.6975.61B3.23B
FY202231 Dec 202222.4218.1860.32B2.69B
FY202131 Dec 202131.0528.7981.87B2.64B
FY202031 Dec 202030.9227.2665.13B2.11B
FY201931 Dec 201933.8829.8271.69B2.12B
FY201831 Dec 201832.8027.5764.40B1.96B
FY201731 Dec 201712.1721.6349.47B4.06B
FY201631 Dec 201625.3824.2938.93B1.53B
FY201531 Dec 201524.4320.2230.46B1.25B
FY201431 Dec 201426.3123.0229.65B1.13B
FY201331 Dec 201326.6923.2826.10B978.10M
FY201231 Dec 201218.5116.8316.78B906.70M
FY201131 Dec 20118.9417.0316.21B1.81B
FY201031 Dec 201022.4019.6821.33B952.10M
FY200931 Dec 200927.0021.7422.30B825.80M
FY200831 Dec 200817.0815.8312.22B715.49M
FY200731 Dec 200745.5843.2830.02B658.53M
FY200631 Dec 200643.4235.3117.69B407.35M
FY200531 Dec 200541.1031.5712.61B306.86M
FY200431 Dec 200434.9426.917.67B219.56M
FY200331 Dec 200319.3711.962.37B122.13M
FY200231 Dec 200213.4913.641.27B94.07M
FY200131 Dec 200118.07—1.23B68.30M
FY200031 Dec 2000——1.23B-5.91M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about CME Group's P/E ratio

Source: Financial Modeling Prep